Kevin R Kelly Selected Research

Kevin R Kelly Research Topics

Disease

17	Neoplasms (Cancer) 10/2023 - 10/2009
9	Multiple Myeloma 10/2023 - 06/2014
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 10/2009
4	Hematologic Neoplasms (Hematological Malignancy) 02/2016 - 10/2009
3	Lymphoma (Lymphomas) 11/2016 - 03/2011
3	Disease Progression 01/2016 - 06/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2018 - 06/2014
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2016 - 06/2014
2	Leukemia 02/2016 - 03/2011
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016 - 06/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2011 - 01/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2016
1	Bone Diseases (Bone Disease) 11/2014
1	Ovarian Neoplasms (Ovarian Cancer) 07/2013
1	Hypoxia (Hypoxemia) 01/2012
1	Starvation 01/2012
1	Pain (Aches) 09/2011
1	Breast Neoplasms (Breast Cancer) 02/2011
1	Neutropenia 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2009

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 11/2017 - 05/2010
4	pevonedistatIBA 01/2015 - 05/2010
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2012
3	RG7388IBA 01/2023 - 01/2016
3	Aurora Kinase AIBA 01/2020 - 06/2014
3	Vorinostat FDA Link 01/2020 - 01/2010
3	MLN 8237IBA 01/2020 - 06/2014
2	venetoclaxIBA 01/2024 - 01/2023
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 11/2021
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2015
2	Rituximab (Mabthera)FDA Link 12/2018 - 11/2017
2	CUDC-907IBA 11/2017 - 01/2016
2	Aurora KinasesIBA 09/2013 - 12/2011
2	Phosphotransferases (Kinase)IBA 09/2013 - 03/2011
2	Antineoplastic Agents (Antineoplastics)IBA 10/2012 - 10/2009
2	temsirolimus FDA Link 03/2011 - 01/2010
2	TOR Serine-Threonine KinasesIBA 03/2011 - 01/2010
1	cobimetinibIBA 01/2024
1	Immunologic Factors (Immunomodulators)IBA 12/2023
1	Bortezomib (Velcade)FDA Link 10/2023
1	Immunomodulating AgentsIBA 11/2021
1	Immunoconjugates (Immunoconjugate)IBA 11/2021
1	indatuximab ravtansineIBA 11/2021
1	Lenalidomide (CC 5013)FDA Link 11/2021
1	pomalidomideIBA 11/2021
1	Histone Deacetylase InhibitorsIBA 01/2020
1	lorvotuzumab mertansineIBA 01/2019
1	Vincristine (Oncovin)FDA LinkGeneric 12/2018
1	10-propargyl-10-deazaaminopterin FDA Link 11/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2016
1	RG7112IBA 02/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	spebrutinibIBA 01/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2016
1	InterleukinsIBA 01/2016
1	Proto-Oncogene Proteins c-mdm2IBA 01/2016
1	Junctional Adhesion Molecule AIBA 12/2015
1	Proteasome InhibitorsIBA 12/2014
1	Monoclonal AntibodiesIBA 11/2014
1	Immunoglobulin G (IgG)IBA 11/2014
1	BHQ880IBA 11/2014
1	Zoledronic Acid (Zometa)FDA Link 11/2014
1	Heme (Haem)IBA 06/2014
1	MSC1992371AIBA 09/2013
1	Cisplatin (Platino)FDA LinkGeneric 07/2013
1	epothilone B (EPO906)IBA 06/2013
1	UbiquitinIBA 10/2012
1	Ligases (Synthetase)IBA 10/2012
1	Cullin Proteins (Cullins)IBA 10/2012
1	MTOR InhibitorsIBA 03/2011
1	Sirolimus (Rapamycin)FDA Link 03/2011
1	Everolimus FDA Link 03/2011
1	ridaforolimusIBA 03/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2011
1	LucanthoneIBA 02/2011
1	Cathepsin DIBA 02/2011
1	Chloroquine (Aralen)FDA LinkGeneric 02/2011
1	Adenosine Triphosphate (ATP)IBA 02/2011
1	IntegrinsIBA 01/2011
1	N- (3- cyano- 4- methyl- 1H- indol- 7- yl)- 3- cyanobenzene- sulfonamideIBA 01/2011
1	SulfonamidesIBA 01/2011
1	SurvivinIBA 01/2010
1	laromustine (VNP40101M)IBA 10/2009
1	Alkylating AgentsIBA 10/2009
1	Gemcitabine FDA Link 06/2009

Therapy/Procedure

10	Therapeutics 01/2024 - 03/2011
5	Drug Therapy (Chemotherapy) 01/2024 - 06/2009
1	Immunomodulation 12/2023
1	Oncolytic Virotherapy 10/2023
1	Intravenous Infusions 06/2013
1	Punctures 09/2011